In pancreatic disease, trauma, and surgery, pancreatic fistula still pose a serious hazard. Surgery remains a crucial component of treatment despite the fact that it has received very little attention in the literature, despite the fact that improved diagnostic and treatment methods, particularly endoscopic procedures, have led to noticeably better outcomes. A soft pancreatic texture and a major pancreatic duct diameter of 3 mm or less have been identified as the two most significant risk factors. Anastomotic leakage prevention has been researched using a variety of surgical procedures, but none have been proven to be more effective than others. Somatostatin analogue use is still a contentious topic. The majority of the time, conservative care of Postoperative pancreatic fistula is successful, however surgical management may be required in patients with sepsis and a deteriorating clinical condition. Percutaneous endoscopic gastrostomy was developed as an alternative to conventional surgical techniques. With percutaneous approaches, the reported morbidity and death rates have been at least as good as those for operational treatments. Patient acceptance has been high while costs have been lower.
Published Date: 2022-12-23; Received Date: 2022-12-03
